Skip to main content

BioTech

#TradeTalks: The Saliva-Based CRL Rapid Response Test is Focused on Getting Businesses Back to Work

Published

Sep 10, 2021

The saliva-based CRL Rapid Response Test is focused on getting businesses and schools back to work. Clinical Reference Laboratories CEO Robert Thompson joins Jill Malandrino on Nasdaq #TradeTalks to discuss.

No transcript available

More in this Series

See all

A Drug Being Developed to Treat Anxiety and Cognitive Decline in the Elderly

Aug 9, 2023
Making Drugs Better by Turning Injectable Drugs Into Pill Form

Aug 9, 2023
Powering Healthcare Ventures: Alpha Healthcare Acquisition Corp III

Jul 6, 2023

My Quotes
My European Quotes
Watchlist
Portfolio

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/

Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Go to Smart Portfolio